CA2877901A1 - Fenofibrate formulation - Google Patents

Fenofibrate formulation Download PDF

Info

Publication number
CA2877901A1
CA2877901A1 CA2877901A CA2877901A CA2877901A1 CA 2877901 A1 CA2877901 A1 CA 2877901A1 CA 2877901 A CA2877901 A CA 2877901A CA 2877901 A CA2877901 A CA 2877901A CA 2877901 A1 CA2877901 A1 CA 2877901A1
Authority
CA
Canada
Prior art keywords
granules
fenofibrate
weight
beads
surfactant
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA2877901A
Other languages
English (en)
French (fr)
Inventor
Sarat C. Chattaraj
Glenn Allen Redelman
Andrew Alan Shaw
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Mylan Inc
Original Assignee
Mylan Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mylan Inc filed Critical Mylan Inc
Publication of CA2877901A1 publication Critical patent/CA2877901A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
    • A61K9/1623—Sugars or sugar alcohols, e.g. lactose; Derivatives thereof; Homeopathic globules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4808—Preparations in capsules, e.g. of gelatin, of chocolate characterised by the form of the capsule or the structure of the filling; Capsules containing small tablets; Capsules with outer layer for immediate drug release
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin
    • A61K9/5042—Cellulose; Cellulose derivatives, e.g. phthalate or acetate succinate esters of hydroxypropyl methylcellulose
    • A61K9/5047—Cellulose ethers containing no ester groups, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • A61K9/5078—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics

Landscapes

  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
CA2877901A 2012-06-25 2012-06-25 Fenofibrate formulation Abandoned CA2877901A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US2012/043971 WO2014003706A1 (en) 2012-06-25 2012-06-25 Fenofibrate formulation

Publications (1)

Publication Number Publication Date
CA2877901A1 true CA2877901A1 (en) 2014-01-03

Family

ID=49783663

Family Applications (1)

Application Number Title Priority Date Filing Date
CA2877901A Abandoned CA2877901A1 (en) 2012-06-25 2012-06-25 Fenofibrate formulation

Country Status (5)

Country Link
EP (1) EP2863890A4 (https=)
BR (1) BR112014032579A2 (https=)
CA (1) CA2877901A1 (https=)
IN (1) IN2014DN11044A (https=)
WO (1) WO2014003706A1 (https=)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101925590B1 (ko) * 2016-08-30 2018-12-05 대원제약 주식회사 개선된 생체이용률을 갖는 페노피브릭산 제제

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2627696B1 (fr) 1988-02-26 1991-09-13 Fournier Innovation Synergie Nouvelle forme galenique du fenofibrate
US7374779B2 (en) * 1999-02-26 2008-05-20 Lipocine, Inc. Pharmaceutical formulations and systems for improved absorption and multistage release of active agents
US7863331B2 (en) * 1999-07-09 2011-01-04 Ethypharm Pharmaceutical composition containing fenofibrate and method for the preparation thereof
US8586094B2 (en) * 2000-09-20 2013-11-19 Jagotec Ag Coated tablets
US20080241070A1 (en) * 2000-09-21 2008-10-02 Elan Pharma International Ltd. Fenofibrate dosage forms
EP1853249A2 (en) * 2005-02-10 2007-11-14 LifeCycle Pharma A/S A stable pharmaceutical composition comprising a fixed dose combination of fenofibrate and an hmg-coa reductase inhibitor
US20090252787A1 (en) * 2006-07-28 2009-10-08 Dr. Reddy's Laboratories Ltd. Granular pharmaceutical compositions
FR2940118B1 (fr) * 2008-12-24 2013-08-09 Ethypharm Sa Formulation pharmaceutique de fenofibrate nanonise
WO2010078429A1 (en) 2008-12-30 2010-07-08 Impax Laboratories, Inc. Pharmaceutical dosage forms and methods of manufacturing same
US20110217369A1 (en) * 2009-09-03 2011-09-08 Ranbaxy Laboratories Limited Fenofibrate compositions

Also Published As

Publication number Publication date
EP2863890A1 (en) 2015-04-29
WO2014003706A1 (en) 2014-01-03
BR112014032579A2 (pt) 2017-06-27
EP2863890A4 (en) 2015-12-09
IN2014DN11044A (https=) 2015-09-25

Similar Documents

Publication Publication Date Title
JP6356215B2 (ja) エベロリムスを含む医薬組成物
JP4789806B2 (ja) パントプラゾール多粒子処方
JP6368242B2 (ja) ４０−ｏ−（２−ヒドロキシ）エチル−ラパマイシンを含む医薬組成物
JP2011063611A (ja) シロスタゾール製剤
JP4748839B2 (ja) シロスタゾール製剤
JP2002523443A (ja) オメプラゾール製剤
EP1490031A1 (en) Fast melt multiparticulate formulations for oral delivery
WO2022144919A1 (en) Extended release pharmaceutical compositions of riociguat
WO2013123965A1 (en) A fixed dose pharmaceutical formulation
UA82268C2 (uk) Гранули, що містять гідрохлорид венлафаксину, та спосіб їх виготовлення
CN111617258A (zh) 一种制备阿比特龙或其衍生物药物组合物的方法及其应用
WO2003070223A1 (en) Sustained release preparations and process for producing the same
US8722083B2 (en) Fenofibrate formulation
US9949933B2 (en) Fenofibrate formulation
CA2877901A1 (en) Fenofibrate formulation
JP3929522B2 (ja) 難水溶性薬物の徐放性製剤
JP5171626B2 (ja) 水難溶性薬物含有球形素顆粒の製造方法
CN104114157A (zh) 包括兰索拉唑的口服配制品及其制备方法
WO2018102526A1 (en) Pharmaceutical dosage form
WO2018130943A1 (en) Oral pharmaceutical composition of lurasidone and preparation thereof
CN118695853A (zh) Cyp11a1抑制剂的药物组合物
US20100034887A1 (en) Bursting Pellets
HU227115B1 (en) Pellets containing pyridazinone derivative
HK1098364B (en) Pellets containing venlafaxine hydrochloride

Legal Events

Date Code Title Description
EEER Examination request

Effective date: 20170608

FZDE Discontinued

Effective date: 20200107